Bienville Capital Management, LLC
Position in CNTN — Canton Strategic Holdings, Inc.
CIK 1605070
New York, NY
Position in CNTN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,834,147
+$1,125,205 QoQ
Shares Held
650,407
+200.0% QoQ
Ownership
0.816%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#9
of 68 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CNTN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bienville Capital Management, LLC holds $2,047,201 across 2 Biotechnology names. CNTN ranks #1 (89.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CNTN |
Canton Strategic Holdings, Inc.
This page
|
650,407 | $1,834,147 | |
| 2 | RXRX |
Recursion Pharmaceuticals, Inc.
|
58,053 | $213,054 |
All Filings in CNTN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,834,147 | 650,407 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $708,942 | 216,802 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||